148 related articles for article (PubMed ID: 25759188)
1. Chest-Wall Metastasis of Prostate Cancer.
Matei V; Bhushan S
J Gen Intern Med; 2015 Dec; 30(12):1888. PubMed ID: 25759188
[No Abstract] [Full Text] [Related]
2. Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.
Hanyok BT; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Posadas EM; Freedland SJ
Cancer; 2016 Jan; 122(2):222-9. PubMed ID: 26484853
[TBL] [Abstract][Full Text] [Related]
3. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between pretreatment serum levels of prostate specific antigen and bone metastasis in prostate cancer].
Kageyama Y; Kihara K; Kamata S; Nagahama K; Yonese J; Fukuda H; Tosaka A; Nagamatsu H; Ishizaka K; Tsujii T; Kitahara S; Morita T; Oshima H
Hinyokika Kiyo; 1996 Mar; 42(3):197-9. PubMed ID: 8619388
[TBL] [Abstract][Full Text] [Related]
5. Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone.
Wu SL; Jones E; Gulley JL; Arlen PM; Chen CC; Figg WD; Dahut WL
BJU Int; 2007 Mar; 99(3):525-8. PubMed ID: 17155971
[TBL] [Abstract][Full Text] [Related]
6. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
7. [Intraoperative scintigraphic visualization of a single rib metastasis from operated prostatic adenocarcinoma].
Sanjurjo S; Hamida W; Letesson G; Hustinx R; Gillet P; Andrianne R
Prog Urol; 2008 Jun; 18(6):402-5. PubMed ID: 18558331
[TBL] [Abstract][Full Text] [Related]
8. Correlation between bone metabolic markers and bone scan in prostatic cancer.
Maeda H; Koizumi M; Yoshimura K; Yamauchi T; Kawai T; Ogata E
J Urol; 1997 Feb; 157(2):539-43. PubMed ID: 8996351
[TBL] [Abstract][Full Text] [Related]
9. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.
Ozcan Kara P; Kara T; Kara Gedik G; Sari O; Sahin O
Rev Esp Med Nucl; 2011; 30(2):94-6. PubMed ID: 21342722
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of [90Y] yttrium-capromab pendetide in the treatment of men with prostate cancer recurrence following radical prostatectomy.
Kahn D; Austin JC; Maguire RT; Miller SJ; Gerstbrein J; Williams RD
Cancer Biother Radiopharm; 1999 Apr; 14(2):99-111. PubMed ID: 10850293
[TBL] [Abstract][Full Text] [Related]
11. Soft tissue extension of bony metastasis identified by bone scanning.
Williamson BR; Bray ST; Teates CD; Lees RF; Croft BY; Cochrane JA
Va Med; 1979 Sep; 106(9):668-9. PubMed ID: 483999
[No Abstract] [Full Text] [Related]
12. PSA and bone scintigraphy.
Modoni S; Calò E; Nardella G; Ritrovato G; Frusciante V
Int J Biol Markers; 1997; 12(4):158-61. PubMed ID: 9582605
[TBL] [Abstract][Full Text] [Related]
13. Prostate Cancer With Isolated Bony Metastasis: Sternal Struggle.
Corkum MT
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):492-493. PubMed ID: 28581385
[No Abstract] [Full Text] [Related]
14. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
[TBL] [Abstract][Full Text] [Related]
15. Soft-tissue involvement by adenocarcinoma imaged during bone scintigraphy.
Bordy Z; Pasztarak E; Bánsági G; Sik E
Clin Nucl Med; 1997 Jul; 22(7):508. PubMed ID: 9227888
[No Abstract] [Full Text] [Related]
16. [Carcinoma of the prostate: correlation between local staging and systemic progression].
Rosi P; Marzi M; Mearini E; Bracarda S; Valli PP; Petroni PA; Porena M
Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):91-5. PubMed ID: 9162385
[TBL] [Abstract][Full Text] [Related]
17. Case in point. Metastatic carcinoma of the prostate.
Fred HL; Hariharan R
Hosp Pract (1995); 1996 Mar; 31(3):76. PubMed ID: 8596011
[No Abstract] [Full Text] [Related]
18. Bone scanning--who needs it among patients with newly diagnosed prostate cancer?
Hirobe M; Takahashi A; Hisasue S; Kitamura H; Kunishima Y; Masumori N; Iwasawa A; Fujimori K; Hasegawa T; Tsukamoto T
Jpn J Clin Oncol; 2007 Oct; 37(10):788-92. PubMed ID: 17911377
[TBL] [Abstract][Full Text] [Related]
19. Case study: management of advanced prostate cancer with soft tissue metastases.
Kirby R
Prostate Cancer Prostatic Dis; 2005; 8(3):290-2. PubMed ID: 15940287
[No Abstract] [Full Text] [Related]
20. Clinical debut of a prostatic cancer with metastasis in manubrium sterni.
Rodríguez Collar TL; Matos Quesada D; Báez Sarria F
Arch Esp Urol; 2013 Mar; 66(2):251-2. PubMed ID: 23589606
[No Abstract] [Full Text] [Related]
[Next] [New Search]
